Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1036962rdf:typepubmed:Citationlld:pubmed
pubmed-article:1036962lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1036962lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:1036962lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:1036962lifeskim:mentionsumls-concept:C0021492lld:lifeskim
pubmed-article:1036962lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1036962lifeskim:mentionsumls-concept:C0068981lld:lifeskim
pubmed-article:1036962pubmed:issue8lld:pubmed
pubmed-article:1036962pubmed:dateCreated1977-2-24lld:pubmed
pubmed-article:1036962pubmed:abstractTextThe kinetics and metabolism of 17 beta-heptanoyl-17 alpha-ethinyl-4-oestren-3-one-7-3H (7-3H-norethisterone enanthate, NET-En) after i.m. injection in two female subjects is described. 177.4 mg and 174.5 mg NET-En were injected. Maximum 3H-activity in plasma was reached 8 to 14 days after the injection. In terms of NET-En it amounted to 70-100 mug/100 ml. Maximum NET concentration was reached on the 4th to 8th day and amounted to about 1 mug/100 ml. After 4 weeks NET concentration was still about 0.05 to 0.1 mug/100 ml and even after 6 weeks NET was still detectable in plasma. In 14 days the two subjects excreted about 13% of the administered dose in the urine and about 15% and 21%, respectively, in the faeces. On the basis of a rough calculation, the subjects eliminated about 60% and 55% of the radioactivity with urine and faeces within 42 days.lld:pubmed
pubmed-article:1036962pubmed:languageenglld:pubmed
pubmed-article:1036962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1036962pubmed:citationSubsetIMlld:pubmed
pubmed-article:1036962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1036962pubmed:statusMEDLINElld:pubmed
pubmed-article:1036962pubmed:issn0004-4172lld:pubmed
pubmed-article:1036962pubmed:authorpubmed-author:BellmannOOlld:pubmed
pubmed-article:1036962pubmed:authorpubmed-author:GerhardsEElld:pubmed
pubmed-article:1036962pubmed:authorpubmed-author:HeckerWWlld:pubmed
pubmed-article:1036962pubmed:issnTypePrintlld:pubmed
pubmed-article:1036962pubmed:volume26lld:pubmed
pubmed-article:1036962pubmed:ownerNLMlld:pubmed
pubmed-article:1036962pubmed:authorsCompleteYlld:pubmed
pubmed-article:1036962pubmed:pagination1611-4lld:pubmed
pubmed-article:1036962pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:meshHeadingpubmed-meshheading:1036962-...lld:pubmed
pubmed-article:1036962pubmed:year1976lld:pubmed
pubmed-article:1036962pubmed:articleTitleStudies of the kinetics and metabolism of 17 beta-heptanoyl-17 alpha-ethinyl-4-oestren-3-one-7-3H (norethisterone enanthate) in humans following intramuscular injection.lld:pubmed
pubmed-article:1036962pubmed:publicationTypeJournal Articlelld:pubmed